Patents by Inventor LAURA SAUNDERS

LAURA SAUNDERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of making DLL3 antibody drug conjugates
    Patent number: 9358304
    Abstract: Novel modulatators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: June 7, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20160151513
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: January 25, 2016
    Publication date: June 2, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibodies
    Patent number: 9353182
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: May 31, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Kits containing DLL3 antibody drug conjugates
    Patent number: 9352051
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: May 31, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Methods of delivering DLL3 antibody drug conjugates
    Patent number: 9345784
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: May 24, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20160136296
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: January 25, 2016
    Publication date: May 19, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • MULTIVALENT DLL3 ANTIBODIES
    Publication number: 20160130331
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: January 11, 2016
    Publication date: May 12, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Multivalent DLL3 antibodies
    Patent number: 9334318
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: May 10, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20160075779
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 17, 2016
    Applicant: STEMCENTRX, INC.
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20150328332
    Abstract: Pharmaceutical compositions to treat proliferative disorders are provided.
    Type: Application
    Filed: July 23, 2015
    Publication date: November 19, 2015
    Applicant: STEMCENTRX, INC.
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9173959
    Abstract: Pharmaceutical compositions to treat proliferative disorders are provided.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: November 3, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9155803
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat tumors having neuroendocrine features are provided.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 13, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
    Publication number: 20150265724
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat tumors having neuroendocrine features are provided.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Applicant: STEMCENTRX, INC.
    Inventors: Robert A. Stull, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9133271
    Abstract: Provide are novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat recurrent tumors and to reduce or inhibit tumor recurrence in a subject.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: September 15, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates for treating cancer
    Patent number: 9107961
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: August 18, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibodies
    Patent number: 9089615
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies
    Patent number: 9090683
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9089617
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9089616
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9011854
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: April 21, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao